Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is a folate analog that inhibits dihydrofolate reductase, potentially reducing the availability of folate and affecting MTHFD1L expression. | ||||||
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid | 137281-23-3 | sc-479733 | 250 mg | $330.00 | 1 | |
Pemetrexed is a multitargeted antifolate that inhibits several enzymes in the folate pathway, possibly impacting MTHFD1L expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil is metabolized to fluorodeoxyuridine monophosphate (FdUMP), which may disrupt the folate cycle, potentially affecting MTHFD1L levels. | ||||||
Raltitrexed | 112887-68-0 | sc-219933 | 10 mg | $146.00 | ||
Raltitrexed is a thymidylate synthase inhibitor, which may lead to imbalances in folate metabolism, potentially influencing MTHFD1L expression. | ||||||
Sulfamethoxazole | 723-46-6 | sc-208405 sc-208405A sc-208405B sc-208405C | 10 g 25 g 50 g 100 g | $37.00 $55.00 $69.00 $109.00 | 5 | |
Sulfamethoxazole is a sulfonamide antibiotic that inhibits dihydropteroate synthase in the folate synthesis pathway, potentially affecting MTHFD1L expression. | ||||||
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $80.00 $238.00 $825.00 | 5 | |
Pyrimethamine is a dihydrofolate reductase inhibitor that could lead to reduced folate metabolism and thereby influence MTHFD1L expression. | ||||||
Trimethoprim | 738-70-5 | sc-203302 sc-203302A sc-203302B sc-203302C sc-203302D | 5 g 25 g 250 g 1 kg 5 kg | $67.00 $161.00 $255.00 $721.00 $3401.00 | 4 | |
Trimethoprim inhibits bacterial dihydrofolate reductase, and at high concentrations, it might affect human folate metabolism, potentially impacting MTHFD1L expression. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
3′-Azido-3′-deoxythymidine is a nucleoside reverse transcriptase inhibitor that could disrupt nucleotide synthesis, potentially affecting enzymes like MTHFD1L. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, which may lead to decreased deoxyribonucleotide pools, indirectly affecting MTHFD1L expression. | ||||||
Clofarabine | 123318-82-1 | sc-278864 sc-278864A | 10 mg 50 mg | $185.00 $781.00 | ||
Clofarabine is a purine nucleoside analog that inhibits ribonucleotide reductase and DNA polymerases, potentially influencing MTHFD1L expression. | ||||||